Prosecution Insights
Last updated: April 19, 2026

Examiner: PRIEST, JESSICA MARIE

Tech Center 1600 • Art Units: 1642

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
4
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
12.5%
§102 Novelty
18.8%
§103 Obviousness
43.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18563348 IMMUNOMODULATION OF TUMOR MICROENVIRONMENT Non-Final OA CLS THERAPEUTICS LIMITED
18467957 ANTI-HUMAN LAIR1 ANTIBODIES Non-Final OA TRex Bio, Inc.
17796289 STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL FORMULATIONS Non-Final OA SAMSUNG BIOEPIS CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month